A follicularis lymphoma.

Translated title of the contribution: Follicular lymphoma

A. Illés, L. Krenács, Zita Borbényi

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Follicular lymphoma is one of the most common indolent nodal non-Hodgkin's lymphomas. The follicular lymphoma should be differentiated from other nodal non-germinal centre derived lymphomas. Since bcl-2 gene translocation can be detected in 80-90% of the cases, it could be used for the confirmation of the diagnosis, measure of the treatment efficacy as well as for the evaluation of the prognosis and follow-up of the disease. There is no uniform therapy employed for follicular lymphoma patients. The treatment depends on the histological grade, stage, age and condition of the patients. Since disease cannot be cured by conventional dosage therapy in the vast majority of the cases, a treatment--adjusted to the condition of the patients as well as the stage and grade of the disease--ensuring the longest period and best quality of life should be selected. The authors review the questions of diagnosis and treatment, including the results of radiotherapy and chemotherapy and discuss the role of the interferon-alpha, purine analogues, monoclonal antibodies and high-dose therapy.

Original languageHungarian
Pages (from-to)2253-2261
Number of pages9
JournalOrvosi Hetilap
Volume144
Issue number46
Publication statusPublished - Nov 16 2003

Fingerprint

Follicular Lymphoma
Therapeutics
bcl-2 Genes
Interferon-alpha
Non-Hodgkin's Lymphoma
Lymphoma
Radiotherapy
Monoclonal Antibodies
Quality of Life
Drug Therapy

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Illés, A., Krenács, L., & Borbényi, Z. (2003). A follicularis lymphoma. Orvosi Hetilap, 144(46), 2253-2261.

A follicularis lymphoma. / Illés, A.; Krenács, L.; Borbényi, Zita.

In: Orvosi Hetilap, Vol. 144, No. 46, 16.11.2003, p. 2253-2261.

Research output: Contribution to journalArticle

Illés, A, Krenács, L & Borbényi, Z 2003, 'A follicularis lymphoma.', Orvosi Hetilap, vol. 144, no. 46, pp. 2253-2261.
Illés A, Krenács L, Borbényi Z. A follicularis lymphoma. Orvosi Hetilap. 2003 Nov 16;144(46):2253-2261.
Illés, A. ; Krenács, L. ; Borbényi, Zita. / A follicularis lymphoma. In: Orvosi Hetilap. 2003 ; Vol. 144, No. 46. pp. 2253-2261.
@article{fe186701b69d4156b644149c1e37e6ce,
title = "A follicularis lymphoma.",
abstract = "Follicular lymphoma is one of the most common indolent nodal non-Hodgkin's lymphomas. The follicular lymphoma should be differentiated from other nodal non-germinal centre derived lymphomas. Since bcl-2 gene translocation can be detected in 80-90{\%} of the cases, it could be used for the confirmation of the diagnosis, measure of the treatment efficacy as well as for the evaluation of the prognosis and follow-up of the disease. There is no uniform therapy employed for follicular lymphoma patients. The treatment depends on the histological grade, stage, age and condition of the patients. Since disease cannot be cured by conventional dosage therapy in the vast majority of the cases, a treatment--adjusted to the condition of the patients as well as the stage and grade of the disease--ensuring the longest period and best quality of life should be selected. The authors review the questions of diagnosis and treatment, including the results of radiotherapy and chemotherapy and discuss the role of the interferon-alpha, purine analogues, monoclonal antibodies and high-dose therapy.",
author = "A. Ill{\'e}s and L. Kren{\'a}cs and Zita Borb{\'e}nyi",
year = "2003",
month = "11",
day = "16",
language = "Hungarian",
volume = "144",
pages = "2253--2261",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "46",

}

TY - JOUR

T1 - A follicularis lymphoma.

AU - Illés, A.

AU - Krenács, L.

AU - Borbényi, Zita

PY - 2003/11/16

Y1 - 2003/11/16

N2 - Follicular lymphoma is one of the most common indolent nodal non-Hodgkin's lymphomas. The follicular lymphoma should be differentiated from other nodal non-germinal centre derived lymphomas. Since bcl-2 gene translocation can be detected in 80-90% of the cases, it could be used for the confirmation of the diagnosis, measure of the treatment efficacy as well as for the evaluation of the prognosis and follow-up of the disease. There is no uniform therapy employed for follicular lymphoma patients. The treatment depends on the histological grade, stage, age and condition of the patients. Since disease cannot be cured by conventional dosage therapy in the vast majority of the cases, a treatment--adjusted to the condition of the patients as well as the stage and grade of the disease--ensuring the longest period and best quality of life should be selected. The authors review the questions of diagnosis and treatment, including the results of radiotherapy and chemotherapy and discuss the role of the interferon-alpha, purine analogues, monoclonal antibodies and high-dose therapy.

AB - Follicular lymphoma is one of the most common indolent nodal non-Hodgkin's lymphomas. The follicular lymphoma should be differentiated from other nodal non-germinal centre derived lymphomas. Since bcl-2 gene translocation can be detected in 80-90% of the cases, it could be used for the confirmation of the diagnosis, measure of the treatment efficacy as well as for the evaluation of the prognosis and follow-up of the disease. There is no uniform therapy employed for follicular lymphoma patients. The treatment depends on the histological grade, stage, age and condition of the patients. Since disease cannot be cured by conventional dosage therapy in the vast majority of the cases, a treatment--adjusted to the condition of the patients as well as the stage and grade of the disease--ensuring the longest period and best quality of life should be selected. The authors review the questions of diagnosis and treatment, including the results of radiotherapy and chemotherapy and discuss the role of the interferon-alpha, purine analogues, monoclonal antibodies and high-dose therapy.

UR - http://www.scopus.com/inward/record.url?scp=1442328572&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1442328572&partnerID=8YFLogxK

M3 - Article

C2 - 14702920

AN - SCOPUS:1442328572

VL - 144

SP - 2253

EP - 2261

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 46

ER -